Chemoinformaics analysis of 2-Benzylidenemalonaldehyde
Molecular Weight | 160.172 | nRot | 3 |
Heavy Atom Molecular Weight | 152.108 | nRig | 18 |
Exact Molecular Weight | 160.052 | nRing | 1 |
Solubility: LogS | -3.603 | nHRing | 0 |
Solubility: LogP | 3.344 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 23.6383 |
nHD | 0 | BPOL | 9.76166 |
QED | 0.672 |
Synth | 2.358 |
Natural Product Likeliness | 1.351 |
NR-PPAR-gamma | 0.964 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.043 |
Pgp-sub | 0.017 |
HIA | 0.01 |
CACO-2 | -4.958 |
MDCK | 0.0000118 |
BBB | 0.01 |
PPB | 0.973429 |
VDSS | 0.71 |
FU | 0.0518988 |
CYP1A2-inh | 0.971 |
CYP1A2-sub | 0.692 |
CYP2c19-inh | 0.396 |
CYP2c19-sub | 0.055 |
CYP2c9-inh | 0.733 |
CYP2c9-sub | 0.907 |
CYP2d6-inh | 0.761 |
CYP2d6-sub | 0.493 |
CYP3a4-inh | 0.636 |
CYP3a4-sub | 0.096 |
CL | 5.547 |
T12 | 0.867 |
hERG | 0.078 |
Ames | 0.615 |
ROA | 0.136 |
SkinSen | 0.682 |
Carcinogencity | 0.053 |
EI | 0.911 |
Respiratory | 0.196 |
NR-Aromatase | 0.889 |
Antiviral | No |
Prediction | 0.863912 |